Safety and Efficiency of Method of Exosome Inhalation in COVID-19 Associated Pneumonia (COVID-19EXO2)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04602442 |
|
Recruitment Status : Unknown
Verified October 2020 by Olga Tyumina, State-Financed Health Facility "Samara Regional Medical Center Dinasty".
Recruitment status was: Enrolling by invitation
First Posted : October 26, 2020
Last Update Posted : October 26, 2020
|
Sponsor:
Olga Tyumina
Collaborators:
Clinics of the Federal State Budgetary Educational Institution SSMU
Samara Regional Clinical Hospital V.D. Seredavin
Information provided by (Responsible Party):
Olga Tyumina, State-Financed Health Facility "Samara Regional Medical Center Dinasty"
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Unknown |
|---|---|
| Estimated Primary Completion Date : | August 1, 2021 |
| Estimated Study Completion Date : | December 30, 2021 |